YouTube2Text

Is now a good time to buy Nvidia? — Transcript

by BNN Bloomberg · 2,212 words · 338 segments · language en · Watch on YouTube

Full transcript

  1. 0:00Nvidia is actually regaining some of its
  2. 0:02losses in the pre-market after Wong's
  3. 0:04resignation yesterday. So joining us now
  4. 0:06to give us his take on the recent market
  5. 0:08news is Paul McDonald, chief investment
  6. 0:10officer at Harvest ETFs. Good morning.
  7. 0:12Great to have you join us.
  8. 0:14>> Good morning, Lindsay. Thanks for having
  9. 0:16me.
  10. 0:16>> It's been another interesting week. I
  11. 0:17wonder what impact do you expect the
  12. 0:19resignation of Jensen Wong to have on
  13. 0:21the broader tech industry?
  14. 0:24>> So look, I I think the tech sector has
  15. 0:26been really caught up in a bit of a a
  16. 0:28consolidation period anyway. If you look
  17. 0:30from June to today, it's really been
  18. 0:33oscillating back and forth.
  19. 0:36And so I think the the shorter term
  20. 0:38impact of the blue wave, you know,
  21. 0:40really driving concerns over AI
  22. 0:42infrastructure and data center build
  23. 0:44out,
  24. 0:45we think that's actually just the
  25. 0:47passing of the event.
  26. 0:48And so for for Nvidia particularly,
  27. 0:52it's not the first time a CEO and a
  28. 0:55visionary leader has stepped down and
  29. 0:58for controversial reasons either. So
  30. 1:01again, we would look at this as somewhat
  31. 1:03of a passing of an event and we see this
  32. 1:05actually as an opportunity specifically
  33. 1:08in an Nvidia.
  34. 1:10>> Yeah, I want to ask you more about that
  35. 1:11because you say that as you say, this is
  36. 1:12a good buying opportunity because the
  37. 1:14company still has good fundamentals. But
  38. 1:15like how concerned are you that the man
  39. 1:17who orchestrated a lot of the AI build
  40. 1:19out, who was the big voice behind it,
  41. 1:21will no longer be running the company?
  42. 1:22It sounds as though you say this has
  43. 1:24happened before in other companies and
  44. 1:25and we're just expected to see it happen
  45. 1:27again here.
  46. 1:29>> That would be our view. And look, there
  47. 1:30there's still some uncertainty around,
  48. 1:32you know, what what does this look like
  49. 1:34with, you know, chips being sent over to
  50. 1:36China? That's the unknown.
  51. 1:39I look back to times like with Steve
  52. 1:41Jobs and then to Tim Cook, you know, now
  53. 1:43driving Apple into one of the dominant
  54. 1:45players.
  55. 1:46And so again, some volatility in the
  56. 1:49shorter term. But look, Nvidia has a
  57. 1:52major problem in front of it is it has
  58. 1:55too much demand for its product. Demand
  59. 1:57is far exceeding supply. They've a
  60. 2:00trillion dollars of backlog
  61. 2:03purchases as we look out through 2027
  62. 2:06and 2028. They're, you know, depending
  63. 2:08on your source, they're 80% of the
  64. 2:11overall
  65. 2:12AI accelerator
  66. 2:14chip demand. And so, you know, from our
  67. 2:17perspective, you got a high growth stock
  68. 2:20that is actually trading at a value
  69. 2:22multiple. So November 17th is when they
  70. 2:25when they report earnings.
  71. 2:27And so our PM was looking at it
  72. 2:29yesterday and certainly we saw that
  73. 2:31pullback yesterday to, you know, mid
  74. 2:34teen
  75. 2:35forward earnings multiples, you know,
  76. 2:37somewhat unprecedented. And if you
  77. 2:39actually start to see any signs that the
  78. 2:42earnings are going to continue, it's you
  79. 2:44could easily see a 5x multiple back to
  80. 2:47where it was trading two weeks ago,
  81. 2:49which would put that up, you know, a $50
  82. 2:51movement in the stock. So we were quite
  83. 2:54constructive on NVIDIA in particular
  84. 2:57yesterday. We're we're adding to it
  85. 2:58within our HHIS portfolio.
  86. 3:00>> Okay. All right. So as you mentioned,
  87. 3:02NVIDIA reporting next week, but we're
  88. 3:04also watching Anthropic which is
  89. 3:05expected to to go public at some point
  90. 3:07next week. It's interesting timing now
  91. 3:09for Anthropic to to kind of make this
  92. 3:11decision to go public. How do you see
  93. 3:13that kind of rolling out and is that
  94. 3:15still maybe a good decision by this
  95. 3:16company?
  96. 3:18>> Oh, I think so. I saw last night the the
  97. 3:21IPO is 6x oversubscribed. There is a
  98. 3:24huge amount of demand for it just as
  99. 3:26cloud.
  100. 3:27And so
  101. 3:29we actually we were talking about it on
  102. 3:30the desk that there might even be a
  103. 3:32little bit of a turnover in the in the
  104. 3:34tech space right now as as a source of
  105. 3:36capital
  106. 3:38for the Anthropic IPO. And so
  107. 3:41we'll we'll see how that trades. You
  108. 3:43know, we have a single stock suite of of
  109. 3:45ETFs.
  110. 3:47We we did one on SpaceX and
  111. 3:49we have filed for Anthropic. I can
  112. 3:51assure everyone that it is going to be a
  113. 3:53volatile first trading day as we've
  114. 3:56experienced in these mega IPOs in the
  115. 3:58past. So we could see some actual
  116. 4:00pullback on some of the other tech or
  117. 4:02sources of of capital being um you know
  118. 4:06selling perhaps even some Nvidia uh this
  119. 4:09past week as the you know for that IPO.
  120. 4:13Uh so look we're excited to see it uh
  121. 4:15and uh we don't think that it's going to
  122. 4:17be anything I don't think their timing
  123. 4:19is bad at all and in fact uh from the
  124. 4:21investor's perspective on looking at the
  125. 4:24tech sector we actually see this
  126. 4:26pullback you know over the past past
  127. 4:29couple of months as an opportunity as we
  128. 4:32look out to 2027. Even though rotation
  129. 4:34has happened under the surface uh we
  130. 4:37still see tech as leadership and the
  131. 4:38cycle still continuing.
  132. 4:40>> Hm. Okay so we've been talking a lot
  133. 4:42about tech today but healthcare is
  134. 4:43actually a sector that you're really
  135. 4:44focused on right now. We'll go through
  136. 4:46some specific names in a moment but just
  137. 4:48first off what is it that you like about
  138. 4:49this sector at the moment?
  139. 4:51>> So so look medium long-term fundamentals
  140. 4:53don't change for us. Aging populations,
  141. 4:55developing markets, tech innovation. Uh
  142. 4:58so when we talk about the market and
  143. 5:00that leadership you know everybody says
  144. 5:03oh the market is just it's all AI AI and
  145. 5:05the bears have the microphone right now.
  146. 5:07We're 3% off all-time highs with you
  147. 5:10know 15% EPS growth for the broader
  148. 5:12market next year. But if you look at
  149. 5:14what the best performing sectors this
  150. 5:16year are year to date you know X Energy
  151. 5:20for obvious reasons you've got
  152. 5:22healthcare as number two. You've got
  153. 5:24staples, you've got utilities, you've
  154. 5:26got industrials. 10 out of 11 sectors
  155. 5:28are positive. The breadth has been
  156. 5:29expanding and rotation has been
  157. 5:31happening. And so when I look at what's
  158. 5:33happened in healthcare in particular in
  159. 5:36the shorter term everybody was on the
  160. 5:38tech side of the boat. We've seen that
  161. 5:40rotation happening but when I look at
  162. 5:422027 earnings forecasts have healthcare
  163. 5:46as the second highest growth for 2027.
  164. 5:49That excites us in an area that has some
  165. 5:51structurally long-term positives.
  166. 5:53>> And a specific name that's exciting you
  167. 5:55right now is Boston Scientific. This is
  168. 5:56one of your first picks for today. Tell
  169. 5:58us more about why you like this company.
  170. 6:00>> Well I I don't want to get overly
  171. 6:01excited. I I think this is exactly this
  172. 6:04is exactly
  173. 6:04>> Cautiously optimistic.
  174. 6:06>> Cautiously optimistic. And so I
  175. 6:08typically am
  176. 6:09and we are the horse before the cart
  177. 6:12investors. And so we would like to see
  178. 6:15some reacceleration in operating
  179. 6:17momentum. But we see a stock from a
  180. 6:20technical basis that has been
  181. 6:22consolidating for the better part of
  182. 6:24seven months off a very meaningful
  183. 6:26pullback. Uh they had some structural
  184. 6:29issues with competition. They had a
  185. 6:31cyber attack which we hope and expect it
  186. 6:34to be transitory. But we've also had at
  187. 6:37the same time as some some competition
  188. 6:39causing some margin compression and
  189. 6:41earnings uh compression. We've had the
  190. 6:44multiple for the company
  191. 6:46basically cut in half.
  192. 6:48And so if we start to see and really
  193. 6:51this is um you know when I think about
  194. 6:53the time of year on what stocks are down
  195. 6:55and where tax loss selling may occur,
  196. 6:59this is a name that we'd be looking for
  197. 7:00some
  198. 7:01capitulatory signs of tax loss selling
  199. 7:05abating in what has historically been a
  200. 7:07leading medtech.
  201. 7:08>> Hm. Okay. Uh I'm not sure maybe whether
  202. 7:11you're excited about this next one or
  203. 7:13again cautiously optimistic. Stryker is
  204. 7:15your next pick for today. Tell us more
  205. 7:16about this company.
  206. 7:17>> Again just keeping on that my primary
  207. 7:19sector is healthcare. If you had asked
  208. 7:21me at the start of the year what was
  209. 7:23going to be our best performing
  210. 7:25uh in that area, I would not have said
  211. 7:27uh you know companies like Merck on the
  212. 7:29large pharma side. So important to have
  213. 7:31diversity, but we tend to favor the
  214. 7:33medtechs right now. And I would say
  215. 7:35Stryker fully diversified, um solid
  216. 7:39growth, just a wonderful company. Uh
  217. 7:42they did have some in their orthopedics
  218. 7:44in their hips and knees, a little bit of
  219. 7:46uh of slowing demand of course and
  220. 7:48that's driven by some of the
  221. 7:49inflationary pressures and and the
  222. 7:51consumer that that has slowed. We see
  223. 7:53that as as transient in the area that is
  224. 7:56is really deferring demand. It's not
  225. 7:58like it's demand that is going away. You
  226. 8:00will still need to get those uh
  227. 8:02surgeries. And of course when we think
  228. 8:04about these types of companies and
  229. 8:06barriers to entry, areas like robotic
  230. 8:08assisted surgery with their with their
  231. 8:10make-over robotic systems. You know,
  232. 8:12this this is a company that is
  233. 8:14positioned for
  234. 8:16benefiting from a lot of those
  235. 8:17structural trends I was talking about
  236. 8:19over the medium term. So a great way to
  237. 8:20be in med tech, but also a diversified
  238. 8:24business lines.
  239. 8:25>> Mhm. And then United Health, that's
  240. 8:26another company like right now. Tell us
  241. 8:28about that one.
  242. 8:29>> Yeah, a little bit of a theme in and
  243. 8:30around the the blue wave where we see
  244. 8:32the Affordable Care Act, some of the
  245. 8:34credits that have
  246. 8:36uh and tax incentives. We could see more
  247. 8:38people come back onto exchanges and
  248. 8:41perhaps that causes some of the premiums
  249. 8:44that United Health would would receive
  250. 8:46on their insurance business. But the
  251. 8:48flip side of that is the propensity for
  252. 8:50more people coming into uh and and
  253. 8:54regaining insurance over the call of the
  254. 8:56next two years. Uh that that is a
  255. 8:58possibility. So a potential benefactor
  256. 9:01uh in the very short term from from the
  257. 9:03blue wave. However, that would be a very
  258. 9:07short-term perspective. The medium
  259. 9:09longer term structurally benefits from
  260. 9:12the those longer term thematics. And you
  261. 9:14know, a company that I did have some
  262. 9:16pressures over, call it about 18 months
  263. 9:18ago that were you know, we see them as
  264. 9:21transient. The market appears to seems
  265. 9:23to see they they were transient as well
  266. 9:25as we start to look out at
  267. 9:27re-accelerating growth in through 2027.
  268. 9:29So great quality core staple
  269. 9:32health insurer.
  270. 9:34>> Okay, and we actually do have time to go
  271. 9:35over your last pick as well. This is
  272. 9:37another healthcare company. Ab AbbVie,
  273. 9:40is that how you pronounce this one?
  274. 9:41>> Yeah, AbbVie. So again, wonderful. I'm
  275. 9:44delighted we were able to talk about it
  276. 9:45to get a to get a
  277. 9:48a little bit of diversity because in
  278. 9:49this sector diversity is exceptionally
  279. 9:52important. So AbbVie has done a
  280. 9:54wonderful job
  281. 9:56diversifying their
  282. 9:58their biotech biotech drugs and it's a
  283. 10:01large cap biotech company. And people
  284. 10:03might remember Humira
  285. 10:05used for a multitude of immunological
  286. 10:09uh
  287. 10:10And so that that went off patent. The
  288. 10:12company was able to uh really
  289. 10:15build off of that with their sky sky
  290. 10:19Renvoke drugs and reaccelerate the
  291. 10:22actual top line and bottom line growth.
  292. 10:25Uh and that really of course when you
  293. 10:26have these companies that you
  294. 10:27everybody's worried about a patent
  295. 10:29cliff, but then they're able to really
  296. 10:31build out and show reaccelerate
  297. 10:33reaccelerating growth. The markets
  298. 10:35rewarded them with some multiple
  299. 10:37expansion. We expect that to continue.
  300. 10:38Of course, it is a very well diversified
  301. 10:41uh company and people might know some of
  302. 10:43their other drugs such as Botox and
  303. 10:45other aesthetics. Uh but we like a solid
  304. 10:48company, reasonable valuation, uh decent
  305. 10:51dividend yield. It's been a core for us
  306. 10:53for uh for almost a decade now.
  307. 10:55>> Just before I let you go, I'm curious.
  308. 10:57The we talked about all the
  309. 10:58opportunities you see in the areas you
  310. 10:59like. Is there anything you're staying
  311. 11:01away from right now?
  312. 11:03>> I look I I think we want to be we want
  313. 11:05to be invested. I think we have to be
  314. 11:08allocating to some of the higher growth
  315. 11:10areas on this uh on this pullback. Um
  316. 11:14and so within within some of those areas
  317. 11:17of you know we talk a little bit about
  318. 11:19tech, but there's other areas in some of
  319. 11:21the higher growth that I continue to
  320. 11:23like, but I want to be focused in on
  321. 11:26some of the areas that you know are have
  322. 11:28defensive characteristics as well. So
  323. 11:30utilities look uh look quite promising.
  324. 11:33So I would say within those spaces some
  325. 11:36of the telecoms still need to turn
  326. 11:38through uh and and you know kind of
  327. 11:40stabilize here. Uh and so as we look out
  328. 11:44through 2020 seven, I would say being
  329. 11:47invested is primary. Uh and from from a
  330. 11:50risk perspective being diversified is is
  331. 11:53essential because the market is we are
  332. 11:55in the mid later cycle. So keeping uh
  333. 11:57keeping diversity in in focus I think is
  334. 11:59really important.
  335. 12:00>> Okay. All right. We'll leave it there.
  336. 12:02Paul McDonald, Chief Investment Officer
  337. 12:03at Harvest ETFs. Really appreciate your
  338. 12:05time this morning. Thank you.

About this transcript

This page contains the full transcript of Is now a good time to buy Nvidia? by BNN Bloomberg, generated from the public captions YouTube serves with the video. The transcript has 2,212 words across 338 segments, with the original timestamps preserved so you can click any line to jump to that moment in the embedded player.

What you can do with it

Use the transcript to take notes, quote the speaker, build a study guide, generate a summary with ChatGPT or Claude via the YouTube Summary tool, or export it as a timed subtitle file with YouTube to SRT. You can also re-open it in the transcriber to choose a caption track available on the video.

Free YouTube transcript tool

YouTube2Text is a free YouTube transcript generator — no signup, no daily limit. Paste any YouTube link and get the full transcript instantly, with timestamps, click-to-jump, caption language selection, AI prompts for ChatGPT, Claude, and Gemini, and exports to TXT, SRT, VTT, or Markdown.